Investor Guide: Health & Biotech 2026 featuring Tim Boreham

From drug makers to medical devices to diagnostics, up-and-coming Australian life science companies are proving their mettle in difficult conditions for the sector globally. Don’t look away – our next biotechnology champion could be in the making.

Rise and Shine: Everything you need to know before the ASX opens

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

Red Mountain Mining moves to secure slice of US domestic antimony supply

Red Mountain Mining is shoring up its portfolio of US antimony projects as it moves to secure a place in the domestic supply chain.

Tin developers eye path to production with tight supply and high prices

ASX tin developers have grown increasingly confident they are on a fast-track to production with prices for the metal near record highs.

Guy on Rocks: Nexus looks to Wallbrook gold dig

Guy looks at an emerging Eastern Goldfields player in Nexus Minerals and the upside on what appears to be an imminent move to production.

Why a $2m super balance should be your retirement savings goal